Cargando…

Hypophysitis induced by anti-programmed cell death protein 1 immunotherapy in non-small cell lung cancer: Three case reports

BACKGROUND: Hypophysitis induced by programmed cell death 1 protein (PD-1) immune checkpoint inhibitors is rare and poorly described. We report three patients with non-small cell lung cancer who developed hypophysitis after anti-PD-1 immunotherapy. CASE SUMMARY: Both case 1 and case 2 presented with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Yun, Zhu, Chen-Yu, Lin, Jing, Chen, Wang-Shan, Wang, Yu-Jie, Fu, Hong-Ye, Zhao, Qiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631148/ https://www.ncbi.nlm.nih.gov/pubmed/36338199 http://dx.doi.org/10.12998/wjcc.v10.i30.11049

Ejemplares similares

Immunotherapy-Induced Anterior Hypophysitis
por: Pachika, Pranali S, et al.
Publicado: (2021)

Pneumonitis in Combined Anti-programmed Death-1 Immunotherapy and Radiation Therapy for Renal Cell Carcinoma
por: Yu, Nathan Y, et al.
Publicado: (2018)

Anti–Programmed Cell Death (PD)-1 Immunotherapy for Malignant Tumor: A Systematic Review and Meta-Analysis()
por: Chen, Ran, et al.
Publicado: (2016)

Acute hypophysitis secondary to nivolumab immunotherapy in a patient with metastatic melanoma
por: Kuru, Sugabramya, et al.
Publicado: (2017)

Early Detection of Immune-Mediated Hypophysitis With Use of Checkpoint Inhibitor Immunotherapy
por: Yossef, Kristena, et al.
Publicado: (2022)

Autoimmune hypophysitis
por: Dhanwal, Dinesh K., et al.
Publicado: (2013)

Idiopathic Hypophysitis
por: Amjed, Hafsa, et al.
Publicado: (2021)

Anaplastic large-cell lymphoma with atypical chromosomal translocation t(2;5) and hypophyseal tumor
por: Wang, Lei, et al.
Publicado: (2010)

Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study
por: Amereller, Felix, et al.
Publicado: (2021)

LBODP013 Hypophysitis And Adrenalitis Associated With The Use Of Immunotherapy "clinical Case Report"
por: Ramos, Andres Felipe Garcia, et al.
Publicado: (2022)

Hypercalcaemia secondary to hypophysitis and cortisol deficiency: another immunotherapy-related adverse event
por: Miller, Samuel R, et al.
Publicado: (2022)

A case report of lymphocytic hypophysitis
por: Yu, Stephen, et al.
Publicado: (2021)

Re-immunotherapy with nivolumab plus ipilimumab in advanced non-small cell lung cancer patients previously treated with anti-programmed death-1 and/or anti-programmed death ligand-1 antibodies
por: Imakita, Takuma, et al.
Publicado: (2023)

Hypophysitis: Evaluation and Management
por: Faje, Alexander
Publicado: (2016)

LBODP071 Early Detection Of Immune-mediated Hypophysitis With Use Of Checkpoint Inhibitor Immunotherapy
por: Lai, William, et al.
Publicado: (2022)

Frequency and clinical characteristics of hypophysitis and hypopituitarism in patients undergoing immunotherapy – A systematic review
por: Jacques, Juliana Prudêncio, et al.
Publicado: (2023)

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy
por: Sun, Xuqi, et al.
Publicado: (2020)

In Situ Activation of Pituitary-Infiltrating T Lymphocytes in Autoimmune Hypophysitis
por: Lin, Han-Huei, et al.
Publicado: (2017)

Toxicities of Immunotherapy for Small Cell Lung Cancer
por: Fu, Yang, et al.
Publicado: (2021)

FRI339 Hypophysitis Secondary To Small Vessel Anca Vasculitistreated With Rituximab
por: Carmen Rivadeneira, Ana Del, et al.
Publicado: (2023)

Autoimmune hypophysitis: Anesthetic implications
por: Bakhshi, Rochana G., et al.
Publicado: (2012)

Lymphocytic Hypophysitis: An Underrated Disease
por: Patil, Amruta Ashok, et al.
Publicado: (2022)

Germinoma Misdiagnosed as Lymphocytic Hypophysitis
por: Şahin, Serdar, et al.
Publicado: (2023)

Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient
por: Fu, Yang, et al.
Publicado: (2022)

A Case of Abdominal Pain and Diarrhea Post Immunotherapy: Hypophysitis Associated with Immune Checkpoint Inhibitors
por: Alok, Akankcha, et al.
Publicado: (2022)

FRI342 Hypophysitis Mimicking As Pituitary Adenoma
por: Chao, Alex, et al.
Publicado: (2023)

Computer-assisted three-dimensional quantitation of programmed death-ligand 1 in non-small cell lung cancer using tissue clearing technology
por: Lin, Yen-Yu, et al.
Publicado: (2022)

Inhibition of IRAK1 Is an Effective Therapy for Autoimmune Hypophysitis in Mice
por: Huang, Hsiao-Chen, et al.
Publicado: (2022)

Sick sinus syndrome associated with anti-programmed cell death-1
por: Hsu, Chien-Yi, et al.
Publicado: (2018)

Association of Plasma Epstein-Barr Virus DNA With Outcomes for Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Anti–Programmed Cell Death 1 Immunotherapy
por: Xu, Jian-Ying, et al.
Publicado: (2022)

Langerhans cell histiocytosis in monozygotic twins with central diabetes insipidus and hypophyseal masses
por: Wei, Sung-Tai, et al.
Publicado: (2015)

Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer
por: Liu, Zhi-Hua, et al.
Publicado: (2017)

The safety and efficacy of immunotherapy with anti-programmed cell death 1 monoclonal antibody for lung cancer complicated with Mycobacterium tuberculosis infection
por: Shi, Jinpeng, et al.
Publicado: (2021)

Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma
por: Nie, Run-Cong, et al.
Publicado: (2020)

Clinical course of IgG4-related hypophysitis presenting with focal seizure and relapsing lymphocytic hypophysitis
por: Ngaosuwan, Kanchana, et al.
Publicado: (2015)

Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases
por: Al Jarroudi, Ouissam, et al.
Publicado: (2020)

A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma
por: Zhang, Yi, et al.
Publicado: (2023)

Xanthomatous Hypophysitis: A Case Report and Comprehensive Literature Review
por: Zhu, Jianyu, et al.
Publicado: (2021)

Microsatellite Instability, Epstein–Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer
por: Yu, Hung-Yuan, et al.
Publicado: (2022)

Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management
por: Shen, John, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_psttdoc0549fvltvetr954qapj